erdafitinib
janssen
[]
 #erdafitinib in patients with #cholangiocarcinoma and #fgfr alterations #gi23 orr 60% dcr 100% median pfs 8.4 months patients, caregivers, co-investigators, advocates 
Medical Oncologist.Professor @MDAndersonNews. Author.Phase 1,GI Cancers.#pancreaticcancer, #biliarytractcancers. Tweets are my own